title: High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection.
abstract: Malaria is a significant global health issue, with nearly 200 million cases in 2013 alone. Parasites obtain folate from the host or synthesize it de novo. Folate consumption has increased in many populations, prompting concerns regarding potential deleterious consequences of higher intake. The impact of high dietary folate on the host's immune function and response to malaria has not been examined. Our goal was to determine whether high dietary folate would affect response to malarial infection in a murine model of cerebral malaria. Mice were fed control diets (CD, recommended folate level for rodents) or folic acid-supplemented diets (FASD, 10x recommended level) for 5 weeks before infection with Plasmodium berghei ANKA. Survival, parasitemia, numbers of immune cells and other infection parameters were assessed. FASD mice had reduced survival (p<0.01, Cox proportional hazards) and higher parasitemia (p< 0.01, joint model of parasitemia and survival) compared with CD mice. FASD mice had lower numbers of splenocytes, total T cells, and lower numbers of specific T and NK cell sub-populations, compared with CD mice (p<0.05, linear mixed effects). Increased brain TNFα immunoreactive protein (p<0.01, t-test) and increased liver Abca1 mRNA (p<0.01, t-test), a modulator of TNFα, were observed in FASD mice; these variables correlated positively (rs = 0.63, p = 0.01). Bcl-xl/Bak mRNA was increased in liver of FASD mice (p<0.01, t-test), suggesting reduced apoptotic potential. We conclude that high dietary folate increases parasite replication, disturbs the immune response and reduces resistance to malaria in mice. These findings have relevance for malaria-endemic regions, when considering anti-folate anti-malarials, food fortification or vitamin supplementation programs.
authors.affiliation: Department of Human Genetics, McGill University, McGill University Health Center, Montreal, Quebec, Canada.
authors.forename: Danielle N
authors.initials: DN
authors.lastname: Meadows
authors.affiliation: Department of Human Genetics, McGill University, McGill University Health Center, Montreal, Quebec, Canada.
authors.forename: Renata H
authors.initials: RH
authors.lastname: Bahous
authors.affiliation: Department of Mathematics and Statistics, McGill University, Montreal, Quebec, Canada.
authors.forename: Ana F
authors.initials: AF
authors.lastname: Best
authors.affiliation: Department of Human Genetics, McGill University, McGill University Health Center, Montreal, Quebec, Canada.|Department of Pediatrics, McGill University, McGill University Health Center, Montreal, Quebec, Canada.
authors.forename: Rima
authors.initials: R
authors.lastname: Rozen
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D005492:Folic Acid / Q000009:adverse effects*; D008288:Malaria / Q000188:drug therapy*; D016779:Malaria, Cerebral / Q000188:drug therapy; D051379:Mice; D018512:Parasitemia / Q000188:drug therapy; D010962:Plasmodium berghei / Q000187:drug effects / Q000472:pathogenicity*; D016016:Proportional Hazards Models; D013601:T-Lymphocytes / Q000378:metabolism; D050998:bcl-2 Homologous Antagonist-Killer Protein / Q000235:genetics / Q000378:metabolism; D051020:bcl-X Protein / Q000235:genetics / Q000378:metabolism
chemical_list: D000962:Antimalarials; D050998:bcl-2 Homologous Antagonist-Killer Protein; D051020:bcl-X Protein; D005492:Folic Acid